Micardis® / MicardisPlus® Program for Therapy Optimization With Telmisartan in Cardiovascular Diseases (PROTEKT)

Last updated: October 10, 2014
Sponsor: Boehringer Ingelheim
Overall Status: Completed

Phase

N/A

Condition

Vascular Diseases

Stress

Williams Syndrome

Treatment

N/A

Clinical Study ID

NCT02262637
502.441
502.442, 502.443
  • Ages > 18
  • All Genders

Study Summary

Study to evaluate efficacy and tolerability of Micardis®/MicardisPlus® under usual daily-practice prescribing-conditions with emphasis on effects on endorgan damage in the clientele of cardiologists, nephrologists, and diabetologists

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age >= 18 years

Exclusion

Exclusion Criteria:

  • Age < 18 years

Study Design

Total Participants: 4814
Study Start date:
September 01, 2003
Estimated Completion Date: